Philip Morris International meets with FDA to make its case for Iqos in patent dispute


Philip Morris International met with the Food and Drug Administration on Friday afternoon to present its argument for why the tobacco giant and Altria should be allowed to import and sell Iqos devices in the U.S., CNBC has learned.

A person familiar with the company’s meeting said Philip Morris told the FDA that Iqos is unique, both in its design and ability to convert smokers. Additionally, the company is arguing that the U.S. International Trade Commission overstepped its bounds, given that the FDA is in charge of regulating which tobacco products and alternatives can be sold, this person said.

The meeting with regulators is the latest development in a patent dispute with rival R.J….


0 0 votes
Article Rating

Fed Vice Chair Clarida says another year of inflation like this one would not be ‘a policy success’

Previous article

Climate biggest single opportunity for insurance: Lloyd’s CEO

Next article

You may also like

Notify of
Inline Feedbacks
View all comments

More in Retail